Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 250 | 3 | BREAST CANCER//BREAST//ONCOLOGY | 46676 |
| 39 | 2 | BREAST CANCER//ONCOLOGY//TRASTUZUMAB | 32738 |
| 11910 | 1 | ADJUVANT CHEMOTHERAPY//CLASSICAL CMF//RECENT RESULTS IN CANCER RESEARCH | 973 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ADJUVANT CHEMOTHERAPY | authKW | 118662 | 9% | 4% | 86 |
| 2 | CLASSICAL CMF | authKW | 97170 | 0% | 100% | 3 |
| 3 | RECENT RESULTS IN CANCER RESEARCH | journal | 75655 | 4% | 7% | 35 |
| 4 | CMF | authKW | 74963 | 1% | 18% | 13 |
| 5 | DOSE DENSE | authKW | 74015 | 1% | 19% | 12 |
| 6 | TAXANES | authKW | 70460 | 5% | 4% | 51 |
| 7 | ADEBAR TRIAL | authKW | 64780 | 0% | 100% | 2 |
| 8 | ADJUVANT TAXANES | authKW | 64780 | 0% | 100% | 2 |
| 9 | DOXORUBICIN AND CYCLOPHOSPHAMIDE AC | authKW | 64780 | 0% | 100% | 2 |
| 10 | ENDOCRINE NON RESPONSIVE | authKW | 64780 | 0% | 100% | 2 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 17457 | 69% | 0% | 667 |
| 2 | Medicine, General & Internal | 615 | 13% | 0% | 126 |
| 3 | Obstetrics & Gynecology | 377 | 7% | 0% | 65 |
| 4 | Surgery | 118 | 8% | 0% | 79 |
| 5 | Health Care Sciences & Services | 13 | 1% | 0% | 12 |
| 6 | Pharmacology & Pharmacy | 9 | 5% | 0% | 45 |
| 7 | Health Policy & Services | 2 | 1% | 0% | 5 |
| 8 | Literary Reviews | 2 | 0% | 0% | 1 |
| 9 | Medical Informatics | 2 | 0% | 0% | 3 |
| 10 | Primary Health Care | 1 | 0% | 0% | 2 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | GRP ONCOL COOPERAT CHILENO INVEST | 64780 | 0% | 100% | 2 |
| 2 | UF CANC | 64780 | 0% | 100% | 2 |
| 3 | SWEDISH BREAST CANC GRP | 58299 | 0% | 60% | 3 |
| 4 | AUSTRIAN BREAST COLORECTAL CANC STUDY GRP | 48582 | 0% | 50% | 3 |
| 5 | IBCSG SCI COMM | 43185 | 0% | 67% | 2 |
| 6 | BREAST CANC MED SERV | 37989 | 1% | 8% | 14 |
| 7 | ATUBETSU KU | 32390 | 0% | 100% | 1 |
| 8 | CANC CLIN TRIALS UNIT CACTUS | 32390 | 0% | 100% | 1 |
| 9 | CELL GENE THER Y MOL CELLULAR BIOL | 32390 | 0% | 100% | 1 |
| 10 | CEVON EVIDENCIAS ONCOL | 32390 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | RECENT RESULTS IN CANCER RESEARCH | 75655 | 4% | 7% | 35 |
| 2 | JOURNAL OF CLINICAL ONCOLOGY | 17738 | 10% | 1% | 95 |
| 3 | BREAST CANCER RESEARCH AND TREATMENT | 8756 | 5% | 1% | 45 |
| 4 | BREAST | 8721 | 3% | 1% | 26 |
| 5 | EJC SUPPLEMENTS | 8105 | 1% | 3% | 9 |
| 6 | ANNALS OF ONCOLOGY | 5479 | 4% | 0% | 38 |
| 7 | CLINICAL BREAST CANCER | 4775 | 1% | 1% | 11 |
| 8 | SEMINARS IN ONCOLOGY | 4165 | 3% | 1% | 26 |
| 9 | BREAST CARE | 3480 | 1% | 1% | 8 |
| 10 | ONCOLOGY-NEW YORK | 3071 | 1% | 1% | 12 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ADJUVANT CHEMOTHERAPY | 118662 | 9% | 4% | 86 | Search ADJUVANT+CHEMOTHERAPY | Search ADJUVANT+CHEMOTHERAPY |
| 2 | CLASSICAL CMF | 97170 | 0% | 100% | 3 | Search CLASSICAL+CMF | Search CLASSICAL+CMF |
| 3 | CMF | 74963 | 1% | 18% | 13 | Search CMF | Search CMF |
| 4 | DOSE DENSE | 74015 | 1% | 19% | 12 | Search DOSE+DENSE | Search DOSE+DENSE |
| 5 | TAXANES | 70460 | 5% | 4% | 51 | Search TAXANES | Search TAXANES |
| 6 | ADEBAR TRIAL | 64780 | 0% | 100% | 2 | Search ADEBAR+TRIAL | Search ADEBAR+TRIAL |
| 7 | ADJUVANT TAXANES | 64780 | 0% | 100% | 2 | Search ADJUVANT+TAXANES | Search ADJUVANT+TAXANES |
| 8 | DOXORUBICIN AND CYCLOPHOSPHAMIDE AC | 64780 | 0% | 100% | 2 | Search DOXORUBICIN+AND+CYCLOPHOSPHAMIDE+AC | Search DOXORUBICIN+AND+CYCLOPHOSPHAMIDE+AC |
| 9 | ENDOCRINE NON RESPONSIVE | 64780 | 0% | 100% | 2 | Search ENDOCRINE+NON+RESPONSIVE | Search ENDOCRINE+NON+RESPONSIVE |
| 10 | DOSE DENSIFICATION | 58299 | 0% | 60% | 3 | Search DOSE+DENSIFICATION | Search DOSE+DENSIFICATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |